Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

Genes Chromosomes and Cancer

Volumn 37, Issue 1, 2003, Pages 58-71

  Charest, Alain ^a   Lane, Keara ^a   McMahon, Kevin ^a   Park, Julie ^a   Preisinger, Elizabeth ^a,b   Conroy, Helen ^a   Housman, David ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PROTEIN; PROTEIN FIG; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; ASTROCYTOMA; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 6Q; CHROMOSOME DELETION; ENZYME ACTIVITY; EXON; GENE LOCUS; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTO ONCOGENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CATALYTIC DOMAIN; CERCOPITHECUS AETHIOPS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; COS CELLS; GLIOBLASTOMA; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; ONCOGENE PROTEINS, FUSION; PROTEIN BIOSYNTHESIS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; READING FRAMES; RECEPTOR PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED;

EID: 0037402509     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10207     Document Type: Article

References (41)

1. Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG. 2001. Common themes in the pathogenesis of acute myeloid leukemia. Oncogene 20:5680-5694.
2. Arlinghaus RB. 1998. The involvement of Bcr in leukemias with the Philadelphia chromosome. Crit Rev Oncog 9:1-18.
3. Ausubel F, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. 2001. Current protocols in molecular biology. New York: Wiley.
4. Balsara BR, Testa JR. 2002. Chromosomal imbalances in human lung cancer. Oncogene 21:6877-6883.
5. Blume-Jensen P, Hunter T. 2001. Oncogenic kinase signalling. Nature 411:355-365.
6. Bongarzone I, Butti MG, Fugazzola L, Pacini F, Pinchera A, Vorontsova TV, Demidchik EP, Pierotti MA. 1997. Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas. Genomics 42:252-259.
7. Buchholz M, Boeck W, Fensterer H, Muller F, Wenger C, Michl P, Adler G, Gress TM. 2001. Use of DNA arrays/microarrays in pancreatic research. Pancreatology 1:581-586.
8. Chakraborty S, Senyuk V, Nucifora G. 2001. Genetic lesions and perturbation of chromatin architecture: a road to cell transformation. J Cell Biochem 82:310-325.
9. Charest A, Lane K, McMahon K, Housman DE. 2001. Association of a novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor) protein syntaxin 6. J Biol Chem 276:29456-29465.
10. Dai C, Holland EC. 2001. Glioma models. Biochim Biophys Acta 1551:M19-M27.
11. Danilkovitch-Miagkova A, Zbar B. 2002. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 109:863-867.
12. Dausset J, Ougen P, Abderrahim H, Billauk A, Sambucy JL, Cohen D, Le Paslier D. 1992. The CEPH YAC library. Behring Inst Mitt:13-20.
13. Delaney SJ, Rich DP, Thomson SA, Hargrave MR, Lovelock PK, Welsh MJ, Wainwright BJ. 1993. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat Genet 4:426-431.
14. Faderl S, Albitar M. 2000. Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 14:1267-1288.
15. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU. 1992. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52:4550-4553.
16. Furstenberger G, Senn HJ. 2002. Insulin-like growth factors and cancer. Lancet Oncol 3:298-302.
17. Gupta R, Knight CL, Bain BJ. 2002. Receptor tyrosine kinase mutations in mveloid neoplasms. Br J Haematol 117:489-508.
18. Hannemann JR, Healy LE, Ridge SA, Wiedemann LM. 1998. The second ETV6 allele is not necessarily deleted in acute leukemias with a ETV6/ABL fusion. Genes Chromosomes Cancer 21:256-259.
19. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA. 2002. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33:484-495.
20. Ivell R. 1994. The proopiomelanocortin gene is expressed as both full-length and 5′ runcated transcripts in rodent Leydig cells. Reprod Fertil Dev 6:791-794.
21. Kolomietz E, Meyn MS, Pandita A, Squire JA. 2002. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35:97-112.
22. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE. 2000. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290:138-141.
23. Pandis N, Bardi G, Heim S. 1994. Interrelationship between methodological choices and conceptual models in solid tumor cytogenetics. Cancer Genet Cytogenet 76:77-84.
24. Ponten J, Macintyre EH. 1968. Long term Culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74:465-486.
25. Rego EM, Pandolfi PP. 2002. Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders? Trends Mol Med 8:396-405.
26. Rey JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J. 1987. Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29:201-221.
27. Rodrigues GA, Park M. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol 13:6711-6722.
28. Sainati L, Bolcato S, Montaldi A, Celli P, Stella M, Leszl A, Silvestro L, Perilongo G, Cordero di Monrezemolo L, Basso G. 1996. Cytogenetics of pediatric central nervous system tumors. Cancer Genet Cytogenet 91:13-27.
29. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G. 2002. Molecular mechanisms of RET activation in human cancer. Ann NY Acad Sci 963:116-121.
30. Sara VR, Prisell P, Sjogren B, Persson L, Boethius J, Enberg G. 1986. Enhancement of insulin-like growth factor 2 receptors in glioblastoma. Cancer Lett 32:229-234.
31. Schwab M. 1999. Oncogene amplification in solid tumors. Semin Cancer Biol 9:319-325.
32. Shapiro JR, Pu PY, Mohamed AN, Galicich JH, Ebrahim SA, Shapiro WR. 1993. Chromosome number and carmustine sensitivity in human gliomas. Cancer 71:4007-4021.
33. Sharma S, Birchmeier C, Nikawa J, O'Neill K, Rodgers L, Wigler M. 1989. Characterization of the rosl-gene products expressed in human glioblastoma cell lines. Oncogene Res 5:91-100.
34. Shawver LK, Slamon D, Ullrich A. 2002. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1:117-123.
35. Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, James CD. 2000. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 59:495-503.
36. Spencer-Cisek PA. 2002. The role of growth factors in malignancy: a focus on the epidermal growth factor receptor. Semin Oncol Nurs 18:13-19.
37. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J, Ilan J. 1992. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 89:4874-4878.
38. Wisoff JH, Boyett JM, Berger MS, Brant C, Li H, Yates AJ, McGuire-Cullen P, Turski PA, Sutton LN, Allen JC, Packer RJ, Finlay JL. 1998. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg 89:52-59.
39. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. 1987. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84:6899-6903.
40. Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein B. 1992. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89:2965-2969.
41. Yamada K, Kasama M, Kondo T, Shinoura N, Yoshioka M. 1994. Chromosome studies in 70 brain tumors with special attention to sex chromosome loss and single autosomal trisomy. Cancer Genet Cytogenet 73:46-52.